Skip to content

Study · Randomized controlled trial · 2017

2 results

[Monitoring of neurotrophic factors and cognitive function in patients with traumatic brain injury].

Karakulova YV, Selyanina NV

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 2017Cited by 2 (Europe PMC)

PMID29171486 (opens in a new tab)DOI10.17116/jnevro201711710134-37 (opens in a new tab)PepBankPUB-29171486
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanRandomized controlled trialEfficacy outcome

    In patients with traumatic brain injury, frontal dysfunction scale results improved after Cerebrolysin treatment.

    In plain wordsIn patients with brain injury, frontal dysfunction scale results improved after Cerebrolysin treatment.

    Peptide
    Cerebrolysin
    Outcome
    Direction not reportedFrontal dysfunction scale
    Study

    n: not reported in source

    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    After treatment with cerebrolysin, a significant positive dynamics on the scale of frontal dysfunction and increased levels of serum brain-derived neurotrophic factor were identified.
    2 context sentences
    Summary · context
    Eighty patients, 56 men and 24 women, aged from 18 to 64 years, were examined in acute and long-term periods of the brain injury of moderate severity.
    Summary · context
    An open, comparative, randomized study was performed before and after treatment with cerebrolysin.
  2. 02HumanRandomized controlled trialMechanism

    In patients with traumatic brain injury, serum brain-derived neurotrophic factor increased after Cerebrolysin treatment.

    In plain wordsIn patients with brain injury, blood levels of brain-derived neurotrophic factor increased after Cerebrolysin treatment.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseSerum brain-derived neurotrophic factor
    Study

    n: not reported in source

    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    After treatment with cerebrolysin, a significant positive dynamics on the scale of frontal dysfunction and increased levels of serum brain-derived neurotrophic factor were identified.
    2 context sentences
    Summary · context
    Eighty patients, 56 men and 24 women, aged from 18 to 64 years, were examined in acute and long-term periods of the brain injury of moderate severity.
    Summary · context
    An open, comparative, randomized study was performed before and after treatment with cerebrolysin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.